With over 30,000 participants, the ESC Congress is the world’s biggest cardiology meeting. A record number of abstract submissions – 9,848 – were registered this year, reflecting how the meeting is now the main platform for cardiovascular research. A growing number of abstracts came from outside Europe, reflecting the truly international dimension of the meeting. “Because cardiovascular disease is the main cause of mortality and morbidity and in recognition of the major advances that have been made in this field we felt that prevention and risk factor identification represented a really important theme to highlight” explains Prof Fausto Pinto, chairperson of the Congress Programme Committee. “Entitled ‘Prevention of Cardiovascular Disease from cell to man to society’, our highlight offers the opportunity for doctors, scientists and governments to come together to discuss ways of decreasing the burden of cardiovascular disease on society.” New joint sessions with sister societies, such as the European Society of Medical Oncology, looking at issues such as the cardiovascular effects of oncology drugs, and a new joint session with the European Commission that will explore the issues around how the European Commission supports cardiovascular research are on the programme this year. The ESC Congress is a unique forum bringing together all the different disciplines and players involved in cardiology, including doctors, basic scientists, epidemiologists, nurses, technicians and key opinion leaders. It covers both specific issues in the different disciplines as well as broader issues affecting all fields of cardiology. The European Society of Cardiology (ESC) represents 59,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.